STOCK TITAN

Suvretta and Averill File Schedule 13G Disclosing Stakes in Erasca

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Erasca, Inc. received Schedule 13G disclosures showing that Suvretta Capital Management, LLC and Aaron Cowen report beneficial ownership of 14,502,004 shares, equal to 5.1% of Erasca's common stock. Averill Master Fund, Ltd. reports 12,717,004 shares, or 4.5%. The filings show shared voting and dispositive power for those amounts and state the securities are held in the ordinary course of business and not to change or influence control. The document references Exhibits A and B and carries signatures dated 08/13/2025 with the report tied to the 06/30/2025 event.

Positive

  • Suvretta Capital reports 14,502,004 shares (5.1% of Erasca common stock)
  • Averill Master Fund reports 12,717,004 shares (4.5% of class)

Negative

  • None.

Insights

TL;DR: Institutional positions disclosed — Suvretta and Aaron Cowen report a 5.1% passive stake; Averill holds 4.5%.

The filing quantifies ownership: Suvretta Capital Management and Aaron Cowen each report 14,502,004 shares (5.1%), while Averill Master Fund reports 12,717,004 shares (4.5%). All reported shares show shared voting and dispositive power. The statement is filed on Schedule 13G and includes a certification that the holdings are held in the ordinary course of business and not for the purpose of changing control, which signals passive investor status rather than an active control intent.

TL;DR: Schedule 13G filing indicates passive ownership with shared voting power disclosed and explicit certification of no control intent.

The document identifies reporting persons, their places of organization, and precise share counts and percentages. Item 6 clarifies the Suvretta-reported securities are directly owned by advisory clients and that none of those clients individually exceed 5% of the class, while Suvretta as adviser reports the aggregate 5.1% position. The filing includes Exhibits A and B (joint filing agreement and control-person identification) and signatures by authorized signatories, reinforcing procedural completeness.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Suvretta Capital Management, LLC
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson/General Counsel and Chief Compliance Officer
Date:08/13/2025
Averill Master Fund, Ltd.
Signature:/s/ Andrew Nathanson
Name/Title:Andrew Nathanson/Authorized Signatory
Date:08/13/2025
Aaron Cowen
Signature:/s/ Aaron Cowen
Name/Title:Aaron Cowen
Date:08/13/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

[Exhibit A - Joint Filing Agreement] [Exhibit B - Control Person Identification]

FAQ

What stake did Suvretta Capital report in Erasca (ERAS)?

14,502,004 shares, representing 5.1% of Erasca's common stock according to the Schedule 13G.

What stake did Averill Master Fund report in Erasca (ERAS)?

12,717,004 shares, representing 4.5% of Erasca's common stock as disclosed in the filing.

Does the filing indicate an intent to influence control of Erasca?

No. The filing includes a certification stating the securities are held in the ordinary course of business and were not acquired to change or influence control.

Who are the reporting persons on the Schedule 13G for ERAS?

Suvretta Capital Management, LLC, Averill Master Fund, Ltd., and Aaron Cowen are listed as reporting persons.

What voting and dispositive power is reported?

The filing shows 0 sole voting/dispositive power and shared voting and shared dispositive power of 14,502,004 for Suvretta and Aaron Cowen and 12,717,004 for Averill.
Erasca, Inc.

NASDAQ:ERAS

ERAS Rankings

ERAS Latest News

ERAS Latest SEC Filings

ERAS Stock Data

973.13M
227.87M
11.68%
81.93%
6.6%
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO